StockNews.com Upgrades Molina Healthcare (NYSE:MOH) to Buy

StockNews.com upgraded shares of Molina Healthcare (NYSE:MOH) from a hold rating to a buy rating in a research note issued to investors on Friday morning.

MOH has been the subject of several other reports. Jefferies Financial Group decreased their price target on shares of Molina Healthcare from $354.00 to $297.00 and set a “hold” rating for the company in a research report on Wednesday, July 24th. TD Cowen decreased their target price on shares of Molina Healthcare from $412.00 to $351.00 and set a “buy” rating for the company in a research report on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft cut their price target on shares of Molina Healthcare from $354.00 to $353.00 and set a “hold” rating on the stock in a report on Monday, July 29th. Wells Fargo & Company increased their price objective on Molina Healthcare from $315.00 to $360.00 and gave the company an “equal weight” rating in a report on Monday, August 5th. Finally, Truist Financial lowered their price objective on Molina Healthcare from $440.00 to $400.00 and set a “buy” rating for the company in a research report on Monday, July 15th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $378.00.

Molina Healthcare Price Performance

Shares of MOH opened at $286.52 on Friday. The stock has a market capitalization of $16.79 billion, a PE ratio of 15.55, a PEG ratio of 1.15 and a beta of 0.58. The company has a 50 day moving average price of $338.57 and a 200-day moving average price of $331.56. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.57 and a current ratio of 1.57. Molina Healthcare has a fifty-two week low of $282.96 and a fifty-two week high of $423.92.

Molina Healthcare (NYSE:MOH) last announced its earnings results on Wednesday, July 24th. The company reported $5.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.73 by $0.13. The business had revenue of $9.88 billion for the quarter, compared to analysts’ expectations of $9.75 billion. Molina Healthcare had a return on equity of 28.09% and a net margin of 2.84%. The business’s revenue for the quarter was up 18.7% on a year-over-year basis. During the same quarter last year, the firm earned $5.65 EPS. Equities analysts predict that Molina Healthcare will post 23.5 earnings per share for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total transaction of $339,210.00. Following the completion of the sale, the director now directly owns 18,025 shares in the company, valued at approximately $6,114,260.25. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other Molina Healthcare news, CAO Maurice Hebert sold 393 shares of the company’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total value of $136,182.36. Following the sale, the chief accounting officer now directly owns 9,473 shares of the company’s stock, valued at approximately $3,282,583.96. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total value of $339,210.00. Following the transaction, the director now owns 18,025 shares of the company’s stock, valued at $6,114,260.25. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.10% of the company’s stock.

Institutional Investors Weigh In On Molina Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. PNC Financial Services Group Inc. lifted its stake in shares of Molina Healthcare by 5.5% in the 4th quarter. PNC Financial Services Group Inc. now owns 3,208 shares of the company’s stock valued at $1,159,000 after purchasing an additional 167 shares during the period. Nomura Holdings Inc. acquired a new position in shares of Molina Healthcare in the fourth quarter worth about $430,000. NBC Securities Inc. boosted its stake in shares of Molina Healthcare by 11.9% during the 1st quarter. NBC Securities Inc. now owns 1,509 shares of the company’s stock worth $619,000 after acquiring an additional 160 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of Molina Healthcare by 11.5% during the 1st quarter. GAMMA Investing LLC now owns 330 shares of the company’s stock worth $136,000 after acquiring an additional 34 shares in the last quarter. Finally, Mather Group LLC. acquired a new stake in shares of Molina Healthcare during the 1st quarter valued at about $123,000. Institutional investors and hedge funds own 98.50% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.